Novel Preclinical and Radiopharmaceutical Aspects of [(68)Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

The detection of prostate cancer lesions by PET imaging of the prostate-specific membrane antigen (PSMA) has gained highest clinical impact during the last years. (68)Ga-labelled Glu-urea-Lys(Ahx)-HBED-CC ([(68)Ga]Ga-PSMA-HBED-CC) represents a successful novel PSMA inhibitor radiotracer which has re...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Eder, Matthias, Neels, Oliver, Müller, Miriam, Bauder-Wüst, Ulrike, Remde, Yvonne, Schäfer, Martin, Hennrich, Ute, Eisenhut, Michael, Afshar-Oromieh, Ali, Haberkorn, Uwe, Kopka, Klaus
Format: Artigo
Langue:Inglês
Publié: MDPI 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4113732/
https://ncbi.nlm.nih.gov/pubmed/24983957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph7070779
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires